Another important, clinically evaluated feature of breast cancer is expression of the nuclear Ki67 protein, regarded as a cell proliferation marker since it is abundant in proliferating cells (G1 and S phases of the cell cycle) and is not detectable in dormant cells (G0 and early G1 phase). This evidence concerns the gene MKI67 and breast carcinoma.